z-logo
Premium
Are Generic Drugs Really Inferior Medicines?
Author(s) -
Moore N,
Berdaï D,
Bégaud B
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.168
Subject(s) - clinical pharmacology , brand names , epilepsy , medicine , antiepileptic drug , pharmacology , psychiatry , advertising , business
In this issue Gagne et al . report an elegant case‐crossover study of seizures in patients on antiepileptic drugs. They found that a dispensation episode approximately triples the risk of having a seizure within 21 days, but the risk is not statistically different whether the dispensation was of the same brand‐name or generic drug as previously used or a switch from brand‐name to a generic or from a generic to a brand name. The cause of the seizure might be a delay in taking medication or late redispensation, among others, but apparently the nature of the product dispensed is not relevant in this study; this may alleviate some of the concerns about generic drugs and epilepsy. Clinical Pharmacology & Therapeutics (2010) 88 3, 302–304. doi: 10.1038/clpt.2010.168

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom